Sinocelltech(SH:688520) Sou Hu Cai Jing·2025-08-13 09:30Core Insights - Shenzhou Cell (688520) reported a closing price of 65.06 yuan as of August 13, 2025, with a 0.99% increase and a trading volume of 88,400 hands, amounting to 577 million yuan in transaction value [1] Financial Performance - For Q1 2025, the company reported total revenue of 520 million yuan, a year-on-year decrease of 15.15% - Net profit attributable to shareholders was 63.77 million yuan, down 14.06% year-on-year - Non-recurring net profit was 23.58 million yuan, reflecting a significant decline of 84.98% year-on-year - Current ratio stood at 0.734, quick ratio at 0.606, and debt-to-asset ratio at 94.25% [1] Capital Flow - On the trading day, the net inflow of main funds was 23.39 million yuan, accounting for 4.05% of the transaction value - Large orders saw a net inflow of 16.62 million yuan, representing 2.88% of the transaction value, while medium and small orders experienced net outflows [1] Company Background - Shenzhou Cell Biotechnology Group Co., Ltd. was established in 2007 and is based in Beijing, primarily engaged in technology promotion and application services - The company has a registered capital of 4.45 billion yuan and a paid-in capital of 3.85 billion yuan [1][2]